These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38042381)

  • 1. 3D-printed prednisolone phosphate suppositories with tunable dose and rapid release for the treatment of inflammatory bowel disease.
    Kocabas LI; Ayyoubi S; Tajqurishi M; Quodbach J; Vermonden T; Kok RJ
    Int J Pharm; 2024 Jan; 649():123639. PubMed ID: 38042381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
    Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
    AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.
    Obeid S; Madžarević M; Ibrić S
    Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
    Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
    Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of 3D printing technology for generating hollow-type suppository shells.
    Tagami T; Ito E; Hayashi N; Sakai N; Ozeki T
    Int J Pharm; 2020 Nov; 589():119825. PubMed ID: 32861769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple variable effects in the customisation of fused deposition modelling 3D-printed medicines: A design of experiments (DoE) approach.
    Dos Santos J; Deon M; da Silva GS; Beck RCR
    Int J Pharm; 2021 Mar; 597():120331. PubMed ID: 33540012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
    Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
    Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets.
    Larsen BS; Kissi E; Nogueira LP; Genina N; Tho I
    Eur J Pharm Sci; 2024 Jan; 192():106619. PubMed ID: 37866675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages.
    Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY
    AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing.
    Skowyra J; Pietrzak K; Alhnan MA
    Eur J Pharm Sci; 2015 Feb; 68():11-7. PubMed ID: 25460545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and
    Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring immediate release FDM 3D printed tablets using a quality by design (QbD) approach.
    Than YM; Titapiwatanakun V
    Int J Pharm; 2021 Apr; 599():120402. PubMed ID: 33640426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone.
    Chai X; Chai H; Wang X; Yang J; Li J; Zhao Y; Cai W; Tao T; Xiang X
    Sci Rep; 2017 Jun; 7(1):2829. PubMed ID: 28588251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the effects of geometric scaling and pore structure on drug dose and release of 3D printed solid dosage forms.
    McDonagh T; Belton P; Qi S
    Eur J Pharm Biopharm; 2022 Aug; 177():113-125. PubMed ID: 35779743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.